Vimarsana.com

Latest Breaking News On - Development of therapeutics - Page 1 : vimarsana.com

Genius Equation: Novo, Evotec Launch Accelerator, Evoking Einstein

Genius Equation: Novo, Evotec Launch Accelerator, Evoking Einstein
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Harvard-university
Massachusetts
United-states
Watertown
Cambridge
Cambridgeshire
United-kingdom
Boston
America
Novo-nordisk
Uli-stilz
Novo-nordisk-bio

Novo Nordisk enters new research alliance for diabetes and cardiometabolic diseases

Novo Nordisk enters new research alliance for diabetes and cardiometabolic diseases
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Novo-nordisk-bio
Uli-stilz
Todd-golub
Abroad-center
Development-of-therapeutics
Novo-nordisk
Broad-institute
Novo-nordisk-bio-innovation-hub
Bio-innovation-hub

New research alliance with Novo Nordisk to identify therapeutic targets for type 2 diabetes and cardiometabolic diseases

The Broad Institute of MIT and Harvard today announced a new research alliance with Novo Nordisk aimed at addressing critical unmet clinical needs in diabetes and cardiometabolic diseases. The collaboration will focus on advancing three programs over the next three years. Two programs aim to identify drug targets .

Boston
Massachusetts
United-states
Patrick-ellinor
Todd-golub
Novo-nordisk-bio
Jose-florez
Uli-stilz
Broad-institute
Cardiovascular-disease-initiative
Novo-nordisk
Development-of-therapeutics

Broad Institute of MIT and Harvard announces

The Broad Institute of MIT and Harvard today announced a new research alliance with Novo Nordisk aimed at addressing critical unmet clinical needs in diabetes and cardiometabolic diseases. The collaboration will focus on advancing three programs over the next three years. Two programs aim to identify drug targets for clinically important subtypes of type 2 diabetes, which affects more than 37 million people in the United States alone, and one program aims to unravel the genetic roots of cardiac fibrosis, or scarring of the heart, which occurs in many cardiovascular diseases that can lead to heart dysfunction and failure.

United-states
Cambridge
Cambridgeshire
United-kingdom
Boston
Massachusetts
Uli-stilz
Jose-florez
Novo-nordisk-bio
Patrick-ellinor
Todd-golub
Diabetes-research-group

vimarsana © 2020. All Rights Reserved.